A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

This publication has 21 references indexed in Scilit:

• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
  Biochemical and Biophysical Research Communications, 1987
• Fenofibrate treatment inhibits HMG-CoA reductase activity in mononuclear cells from hyperlipoproteinemic patients
  Atherosclerosis, 1985
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
  JAMA, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
  JAMA, 1984
• Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
  New England Journal of Medicine, 1983
• Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors Determination of apolipoprotein D
  Atherosclerosis, 1980
• Quantitative studies of ver low densit lipoprotein: conversion to low densit lipoprotein in normal controls and primar hperlipidaemic states and the role of direct secretion of low densit lipoprotein in heterozgous familial hpercholesterolaemia
  European Journal of Clinical Investigation, 1980
• SERUM-HIGH-DENSITY-LIPOPROTEIN AND ATHEROSCLEROTIC HEART-DISEASE
  The Lancet, 1976
• Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms
  FEBS Letters, 1974